215 related articles for article (PubMed ID: 31628651)
1. Structures of Immune Checkpoints: An Overview on the CD28-B7 Family.
Liu W; Zang X
Adv Exp Med Biol; 2019; 1172():63-78. PubMed ID: 31628651
[TBL] [Abstract][Full Text] [Related]
2. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.
Janakiram M; Shah UA; Liu W; Zhao A; Schoenberg MP; Zang X
Immunol Rev; 2017 Mar; 276(1):26-39. PubMed ID: 28258693
[TBL] [Abstract][Full Text] [Related]
3. The CD28-B7 Family of Co-signaling Molecules.
Nagai S; Azuma M
Adv Exp Med Biol; 2019; 1189():25-51. PubMed ID: 31758530
[TBL] [Abstract][Full Text] [Related]
4. Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy.
Khan M; Arooj S; Wang H
Front Immunol; 2021; 12():651634. PubMed ID: 34531847
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors win the 2018 Nobel Prize.
Huang PW; Chang JW
Biomed J; 2019 Oct; 42(5):299-306. PubMed ID: 31783990
[TBL] [Abstract][Full Text] [Related]
6. Development of immune checkpoint therapy for cancer.
Fritz JM; Lenardo MJ
J Exp Med; 2019 Jun; 216(6):1244-1254. PubMed ID: 31068379
[TBL] [Abstract][Full Text] [Related]
7. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
8. Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.
Schildberg FA; Klein SR; Freeman GJ; Sharpe AH
Immunity; 2016 May; 44(5):955-72. PubMed ID: 27192563
[TBL] [Abstract][Full Text] [Related]
9. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
Daikh D; Wofsy D; Imboden JB
J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329
[TBL] [Abstract][Full Text] [Related]
10. The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy.
Leung J; Suh WK
Immune Netw; 2014 Dec; 14(6):265-76. PubMed ID: 25550693
[TBL] [Abstract][Full Text] [Related]
11. CD28-B7 interactions in T-cell activation.
Allison JP
Curr Opin Immunol; 1994 Jun; 6(3):414-9. PubMed ID: 7522466
[TBL] [Abstract][Full Text] [Related]
12. T cell co-stimulation and in vivo tolerance.
Lenschow DJ; Bluestone JA
Curr Opin Immunol; 1993 Oct; 5(5):747-52. PubMed ID: 7694594
[TBL] [Abstract][Full Text] [Related]
13. Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer.
Bakacs T; Moss RW; Kleef R; Szasz MA; Anderson CC
Scand J Immunol; 2019 Dec; 90(6):e12821. PubMed ID: 31589347
[TBL] [Abstract][Full Text] [Related]
14. [Lymphocyte coreceptors].
Olive D
Med Sci (Paris); 2006 Dec; 22(12):1069-74. PubMed ID: 17156728
[TBL] [Abstract][Full Text] [Related]
15. Control of autoimmune diseases by the B7-CD28 family molecules.
Anand S; Chen L
Curr Pharm Des; 2004; 10(2):121-8. PubMed ID: 14754392
[TBL] [Abstract][Full Text] [Related]
16. Translation of cancer immunotherapy from the bench to the bedside.
Guo Q; Huang F; Goncalves C; Del Rincón SV; Miller WH
Adv Cancer Res; 2019; 143():1-62. PubMed ID: 31202357
[TBL] [Abstract][Full Text] [Related]
17. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
[TBL] [Abstract][Full Text] [Related]
18. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
19. Targeting co-stimulatory molecules in autoimmune disease.
Edner NM; Carlesso G; Rush JS; Walker LSK
Nat Rev Drug Discov; 2020 Dec; 19(12):860-883. PubMed ID: 32939077
[TBL] [Abstract][Full Text] [Related]
20. B7 immune checkpoint family members as putative therapeutics in autoimmune disease: An updated overview.
Dolatkhah K; Alizadeh N; Mohajjel-Shoja H; Abdoli Shadbad M; Hajiasgharzadeh K; Aghebati-Maleki L; Baghbanzadeh A; Hosseinkhani N; Karim Ahangar N; Baradaran B
Int J Rheum Dis; 2022 Mar; 25(3):259-271. PubMed ID: 34994525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
